Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia
Open Access
- 2 June 2021
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (6) , 2229-2232
Abstract
: Zambia conducted a measles and rubella (MR) vaccination campaign targeting children 9 months to younger than 15 years of age in 2016. This campaign was the first introduction of a rubella-containing vaccine in Zambia. To evaluate the impact of the campaign, we compared the MR seroprevalence estimates from serosurveys conducted before and after the campaign in Southern Province, Zambia. The measles seroprevalence increased from 77.8% (95% confidence interval [CI], 73.2–81.9) to 96.4% (95% CI, 91.7–98.5) among children younger than 15 years. The rubella seroprevalence increased from 51.3% (95% CI, 45.6–57.0) to 98.3% (95% CI, 95.5–99.4). After the campaign, slightly lower seroprevalence remained for young adults 15 to 19 years old, who were not included in the campaign because of their age. These serosurveys highlighted the significant impact of the vaccination campaign and identified immunity gaps for those beyond the targeted vaccination age. Continued monitoring of population immunity can signal the need for future targeted vaccination strategies.Keywords
This publication has 14 references indexed in Scilit:
- Measles and Rubella Seroprevalence Among HIV–infected and Uninfected Zambian YouthThe Pediatric Infectious Disease Journal, 2017
- Issues and considerations in the use of serologic biomarkers for classifying vaccination history in household surveysVaccine, 2014
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010
- Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveysVaccine, 2008
- Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture modelsEpidemiology and Infection, 2008
- Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and AustraliaEpidemiology and Infection, 2007
- The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studiesEpidemiology and Infection, 2000
- Modelling the incidence of congenital rubella syndrome in developing countriesInternational Journal of Epidemiology, 1999
- The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign.1994
- Prevalence of Rubella Antibodies on the African ContinentClinical Infectious Diseases, 1989